Dr. Christopher I. Li

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Epidemiology Program
Associate MemberAppointed: 2006
University of Washington
School of Public Health and Community Medicine
Epidemiology
Research Associate ProfessorAppointed: 2006
Professional Headshot of Christopher I. Li

Mailing Address

1100 Fairview Ave. N.
P.O. Box 19024
M4-C308
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-7444
Fax: (206) 667-5948
cili@fhcrc.org

Qualifications

Ph.D., University of Washington, Epidemiology, 2002.
M.P.H., University of Washington, Epidemiology, 2000.
M.D., University of California, San Francisco, 2000.
B.S., Stanford University, Biological Sciences, 1995.

Expertise and Research Interests

My research interests lie principally in the field of breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. I am actively investigating the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers. I am also interested in breast cancer outcomes and am currently leading studies that investigate risk factors for second primary breast cancer among breast cancer survivors. Another part of my work focuses on identifying markers that could be used for the early detection of different cancers using various proteomic platforms. Finally, I have an interest in examining disparities in cancer stage, treatment, and survival by race/ethnicity.

Keywords

COS Keywords:

Apoptosis, Breast Cancer, Epidemiology, Etiology, Histology, Hormones, Minority Health, Oncogenes, Outcomes Research (Medical).

Additional Terms:

Breast Cancer, Epidemiology, Hormones.

Languages

(Reading, Writing, Speaking)

Spanish: (Basic, Basic, Basic)

Memberships

American Association for Cancer Research

Publications

  • Li CI, Malone KE, Daling JR (Oct 2005) The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States)., Cancer Causes & Control : Ccc, 16 (8), 975-85 Abstract
  • Li CI, Racial and Ethnic Disparities in Breast Cancer Stage, Treatment, And Survival in the United States., Ethnicity & Disease, 15(2 Suppl 2), S5-9, Spring 2005 Abstract
  • Li CI, Daling JR, Malone KE, Age-specific Incidence Rates of in Situ Breast Carcinomas By Histologic Type, 1980 to 2001., Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology., 14(4), 1008-11, Apr 2005 Abstract
  • Voigt LF, Boudreau DM, Weiss NS, Malone KE, Li CI, Daling JR, Re: "studies With Low Response Proportions May Be Less Biased Than Studies With High Response Proportions"., American Journal of Epidemiology, 161(4), 401-2; author reply, Feb 2005 Abstract
  • Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL, Array Comparative Genomic Hybridization Analysis of Genomic Alterations In Breast Cancer Subtypes., Cancer Research, 64(23), 8541-9, Dec 2004 Abstract
  • Li CI, Postmenopausal Hormone Therapy and the Risk of Breast Cancer: the View Of An Epidemiologist., Maturitas, 49(1), 44-50, Sep 2004 Abstract
  • Li CI, Moe RE, Daling JR, Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years, Archives of Internal Medicine, 163(18), 2149-53, October 2003 Abstract
  • Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR, Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years, Cancer, 98(7), 1504-13, October 2003 Abstract
  • Li CI, Malone KE, Porter PL, Daling JR, Epidemiologic and molecular risk factors for contralateral breast cancer among young women, British Journal of Cancer, 89(3), 513-8, August 2003 Abstract
  • Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR, Relationship between long durations and different regimens of hormone therapy and risk of breast cancer, Jama : the Journal of the American Medical Association, 289(24), 3254-63, June 2003 Abstract
  • Li CI, Daling JR, Emanuel I, Birthweight and risk of overall and cause-specific childhood mortality, Paediatric and Perinatal Epidemiology, 17(2), 164-70, April 2003 Abstract
  • Li CI, Anderson BO, Daling JR, Moe RE, Trends in incidence rates of invasive lobular and ductal breast carcinoma, Jama : the Journal of the American Medical Association, 289(11), 1421-4, March 2003 Abstract
  • Li CI, Malone KE, Daling JR, Differences in breast cancer stage, treatment, and survival by race and ethnicity, Archives of Internal Medicine, 163(1), 49-56, January 2003 Abstract
  • Li CI, Daling JR, Malone KE, Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 21(1), 28-34, January 2003 Abstract
  • Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Daling JR, The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age, Cancer Epidemiol Biomarker Prev, 12, 1061-1066, 2003
  • Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Daling JR, Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age, Int J Cancer, 107, 647-651, 2003
  • Li CI, Malone KE, Daling JR, Differences in Breast Cancer Stage, Treatment, and Survival By Race And Ethnicity., Archives of Internal Medicine, 163(1), 49-56, Jan 2003 Abstract
  • Li CI, Malone KE, Daling JR, Differences in Breast Cancer Stage, Treatment, and Survival By Race And Ethnicity., Archives of Internal Medicine, 163(1), 49-56, Jan 2003
  • Li CI, Daling JR, Malone KE, Incidence of Invasive Breast Cancer By Hormone Receptor Status From 1992 to 1998., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 21(1), 28-34, Jan 2003
  • Li CI, Anderson BO, Daling JR, Moe RE, Changing incidence of lobular carcinoma in situ of the breast, Breast Cancer Research and Treatment, 75(3), 259-68, October 2002 Abstract
  • Li CI, Malone KE, Daling JR, Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 11(7), 601-7, July 2002 Abstract
  • Li CI, Malone KE, Weiss NS, Daling JR, Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer, Journal of the National Cancer Institute, 93(13), 1008-13, July 2001 Abstract
  • Li CI, Rossing MA, Voigt LF, Daling JR, Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States), Cancer Causes & Control : Ccc, 11(9), 805-11, October 2000 Abstract
  • Li CI, Weiss NS, Stanford JL, Daling JR, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer, 88(11), 2570-7, June 2000 Abstract
  • Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE, Changing incidence rate of invasive lobular breast carcinoma among older women, Cancer, 88(11), 2561-9, June 2000 Abstract
  • Li CI, Stanford JL, Daling JR, Anthropometric variables in relation to risk of breast cancer in middle-aged women, International Journal of Epidemiology, 29(2), 208-13, April 2000 Abstract
  • van Oers HJ, de Kloet ER, Li C, Levine S, The ontogeny of glucocorticoid negative feedback: influence of maternal deprivation, Endocrinology, 139(6), 2838-46, June 1998 Abstract
  • Li CI, Malone KE, White E, Daling JR, Age when maximum height is reached as a risk factor for breast cancer among young U.S. women, Epidemiology (cambridge, Mass.), 8(5), 559-65, September 1997 Abstract
  • Li SA, Xue Y, Xie Q, Li CI, Li JJ, Serum and tissue levels of estradiol during estrogen-induced renal tumorigenesis in the Syrian hamster, Journal of Steroid Biochemistry and Molecular Biology, 48(2-3), 283-6, February 1994 Abstract

Profile Details

Last Verified: 6/14/2007

COS Expertise ID #1051347
Reference this profile directly: http://myprofile.cos.com/cili